Single-agent gefitinib in patients with untreated advanced non-small-cell lung cancer and poor performance status: a Minnie Pearl Cancer Research Network Phase II Trial

MLA

Suzanne F. Jones, et al. “Single-Agent Gefitinib in Patients with Untreated Advanced Non-Small-Cell Lung Cancer and Poor Performance Status: A Minnie Pearl Cancer Research Network Phase II Trial.” Clinical Lung Cancer, vol. 7, no. 2, Sept. 2005. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f1741cf04deea854e4283a69b19ecd2c&authtype=sso&custid=ns315887.

APA

Suzanne F. Jones, F. Anthony Greco, Howard A. Burris, David R. Spigel, James R. Rubinsak, Emily R. Burkett, Natalie R. Dickson, Melodie Thomas, Daniel C. Scullin, Joseph E. Brierre, Denise A. Yardley, John D. Hainsworth, & James E. Bradof. (2005). Single-agent gefitinib in patients with untreated advanced non-small-cell lung cancer and poor performance status: a Minnie Pearl Cancer Research Network Phase II Trial. Clinical Lung Cancer, 7(2).

Chicago

Suzanne F. Jones, F. Anthony Greco, Howard A. Burris, David R. Spigel, James R. Rubinsak, Emily R. Burkett, Natalie R. Dickson, et al. 2005. “Single-Agent Gefitinib in Patients with Untreated Advanced Non-Small-Cell Lung Cancer and Poor Performance Status: A Minnie Pearl Cancer Research Network Phase II Trial.” Clinical Lung Cancer 7 (2). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....f1741cf04deea854e4283a69b19ecd2c&authtype=sso&custid=ns315887.